Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Melanocortins as Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives.
B cell exchange across the blood-brain barrier in multiple sclerosis.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Vitamin D status and ill health: a systematic review.
Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Curcuminoids in Neurodegenerative Diseases.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
The intention to exercise and the execution of exercise among persons with multiple sclerosis - a qualitative metasynthesis.
Sphingolipids in ocular inflammation.
Mitochondrial changes within axons in multiple sclerosis: an update.
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
Dark microglia: A new phenotype predominantly associated with pathological states.
Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
A case of septal panniculitis secondary to interferon treatment.
Averting inflammation by targeting the cytokine environment.
Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
Nrf2 in health and disease: current and future clinical implications.
Pages
« first
‹ previous
…
196
197
198
199
200
201
202
203
204
…
next ›
last »